Literature DB >> 10233934

Dengue virus structural differences that correlate with pathogenesis.

K C Leitmeyer1, D W Vaughn, D M Watts, R Salas, I Villalobos, C Ramos, R Rico-Hesse.   

Abstract

The understanding of dengue virus pathogenesis has been hampered by the lack of in vitro and in vivo models of disease. The study of viral factors involved in the production of severe dengue, dengue hemorrhagic fever (DHF), versus the more common dengue fever (DF), have been limited to indirect clinical and epidemiologic associations. In an effort to identify viral determinants of DHF, we have developed a method for comparing dengue type 2 genomes (reverse transcriptase PCR in six fragments) directly from patient plasma. Samples for comparison were selected from two previously described dengue type 2 genotypes which had been shown to be the cause of DF or DHF. When full genome sequences of 11 dengue viruses were analyzed, several structural differences were seen consistently between those associated with DF only and those with the potential to cause DHF: a total of six encoded amino acid charge differences were seen in the prM, E, NS4b, and NS5 genes, while sequence differences observed within the 5' nontranslated region (NTR) and 3' NTR were predicted to change RNA secondary structures. We hypothesize that the primary determinants of DHF reside in (i) amino acid 390 of the E protein, which purportedly alters virion binding to host cells; (ii) in the downstream loop (nucleotides 68 to 80) of the 5' NTR, which may be involved in translation initiation; and (iii) in the upstream 300 nucleotides of the 3' NTR, which may regulate viral replication via the formation of replicative intermediates. The significance of four amino acid differences in the nonstructural proteins NS4b and NS5, a presumed transport protein and the viral RNA polymerase, respectively, remains unknown. This new approach to the study of dengue virus genome differences should better reflect the true composition of viral RNA populations in the natural host and permit their association with pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233934      PMCID: PMC112516     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.

Authors:  F A Rey; F X Heinz; C Mandl; C Kunz; S C Harrison
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

2.  Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome.

Authors:  A Cahour; A Pletnev; M Vazielle-Falcoz; L Rosen; C J Lai
Journal:  Virology       Date:  1995-02-20       Impact factor: 3.616

Review 3.  Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome.

Authors:  I Kurane; A L Rothman; P G Livingston; S Green; S J Gagnon; J Janus; B L Innis; S Nimmannitya; A Nisalak; F A Ennis
Journal:  Arch Virol Suppl       Date:  1994

4.  Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA.

Authors:  H Sumiyoshi; G H Tignor; R E Shope
Journal:  J Infect Dis       Date:  1995-05       Impact factor: 5.226

5.  Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice.

Authors:  A G Pletnev; M Bray; C J Lai
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

6.  Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence.

Authors:  W R Jiang; A Lowe; S Higgs; H Reid; E A Gould
Journal:  J Gen Virol       Date:  1993-05       Impact factor: 3.891

7.  Computer-assisted identification of a putative methyltransferase domain in NS5 protein of flaviviruses and lambda 2 protein of reovirus.

Authors:  E V Koonin
Journal:  J Gen Virol       Date:  1993-04       Impact factor: 3.891

8.  The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants.

Authors:  M Lobigs; C E Arthur; A Müllbacher; R V Blanden
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

9.  Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.

Authors:  R M Kinney; G J Chang; K R Tsuchiya; J M Sneider; J T Roehrig; T M Woodward; D W Trent
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA.

Authors:  R Andino; G E Rieckhof; P L Achacoso; D Baltimore
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  181 in total

1.  Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response.

Authors:  R G van Der Most; K Murali-Krishna; R Ahmed; J H Strauss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Infection of human cells by dengue virus is modulated by different cell types and viral strains.

Authors:  M S Diamond; D Edgil; T G Roberts; B Lu; E Harris
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis.

Authors:  Dixon Grant; Grace K Tan; Min Qing; Jowin K W Ng; Andy Yip; Gang Zou; Xuping Xie; Zhiming Yuan; Mark J Schreiber; Wouter Schul; Pei-Yong Shi; Sylvie Alonso
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

4.  Virus isolation for diagnosing dengue virus infections in returning travelers.

Authors:  D Teichmann; K Göbels; M Niedrig; J-W Sim-Brandenburg; J Làge-Stehr; M P Grobusch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-17       Impact factor: 3.267

5.  Phylogenetic analysis of the envelope protein (domain III) of dengue 4 viruses.

Authors:  Javier Mota; José Ramos-Castañeda; Rebeca Rico-Hesse; Celso Ramos
Journal:  Salud Publica Mex       Date:  2002 May-Jun

6.  Diverse dengue type 2 virus populations contain recombinant and both parental viruses in a single mosquito host.

Authors:  Scott Craig; Hlaing Myat Thu; Kym Lowry; Xiao-fang Wang; Edward C Holmes; John Aaskov
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 7.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Mouse STAT2 restricts early dengue virus replication.

Authors:  Joseph Ashour; Juliet Morrison; Maudry Laurent-Rolle; Alan Belicha-Villanueva; Courtney Ray Plumlee; Dabeiba Bernal-Rubio; Katherine L Williams; Eva Harris; Ana Fernandez-Sesma; Christian Schindler; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

9.  Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity.

Authors:  Poornima Parameswaran; Patrick Charlebois; Yolanda Tellez; Andrea Nunez; Elizabeth M Ryan; Christine M Malboeuf; Joshua Z Levin; Niall J Lennon; Angel Balmaseda; Eva Harris; Matthew R Henn
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

10.  Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion.

Authors:  Carey L Medin; Katherine A Fitzgerald; Alan L Rothman
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.